A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

…, Y Sherrer, S Baca, B Walsh, D Ferland… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate treatment with methotrexate (MTX) in patients with newly diagnosed
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …

Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery

…, MH Liang, M Tanzer, D Ferland… - … : Official Journal of …, 1999 - Wiley Online Library
Objective To determine whether patients with knee or hip osteoarthritis (OA) who have
worse physical function preoperatively achieve a postoperative status that is similar to that of …

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee

…, L Joseph, P Bélisle, MH Liang, D Ferland… - Arthritis & …, 2002 - Wiley Online Library
Objective To determine the predictors of outcome in patients with osteoarthritis 2 years after
receiving total hip or knee replacement. Methods A prospective cohort study of 222 …

Steroid‐sparing effects of methotrexate in systemic lupus erythematosus: a double‐blind, randomized, placebo‐controlled trial

PR Fortin, M Abrahamowicz, D Ferland… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To assess the potential benefits of methotrexate in patients with systemic lupus
erythematosus (SLE). Methods A 12‐month, double‐blind, placebo‐controlled trial of …

Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.

…, AE Clarke, L Joseph, P Belisle, D Ferland… - The Journal of …, 2000 - europepmc.org
Objective Differences have been described between patient and physician assessments of
well being in several chronic illnesses, and these differences may affect outcome. …

Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort

…, CA Hitchon, G Boire, B Haraoui, DS Ferland… - …, 2012 - academic.oup.com
Objective. To characterize steroid use and compliance with glucocorticoid-induced osteoporosis
(GIOP) guidelines within a large early inflammatory arthritis cohort. Methods. Using the …

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians

E Chang, M Abrahamowicz, D Ferland… - Journal of clinical …, 2002 - Elsevier
Both the revised Systemic Lupus Activity Measure (SLAM-R) and the Systemic Lupus
Erythematosus Disease Activity Index (SLEDAI) are valid and reliable measures of disease activity …

Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus …

ER Chang, M Abrahamowicz, D Ferland… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To determine (1) which organ system manifestations contribute to the overall
responsiveness of the Systemic Lupus Activity Measure (SLAM, revised 1991 with minor …

Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE)

D Ferland, PR Fortin - Lupus, 1999 - journals.sagepub.com
The task of recruiting patients for a research project can prove to be the most difficult aspect
of the entire research process. A large portion of the work of research is devoted to the …

Sequestration and microsomal C-25 hydroxylation of {3H}-vitamin D3 by the rat liver

M Gascon-Barré, H Elbaz, D Therrien-Ferland - Metabolism, 1985 - Elsevier
A study of the vitamin D 3 (D 3 ) 25-hydroxylase was undertaken in an in vivo-in vitro model.
{ 3 H}-D 3 ( 0.7, 1.0, 10, or 100 nmol 100 g of body weight ) was injected into the portal vein …